S Silber

Summary

Country: Germany

Publications

  1. ncbi [Undertreatment in secondary prevention of patients with coronary heart disease after revascularization]
    S Silber
    Herzkatheterlabor, Klinik Dr Müller, Munchen
    Herz 25:623-6. 2000
  2. ncbi [Intracoronary radiation therapy in controlled and open clinical trials with afterloading systems and "hot" balloon catheters. Analysis of 6,692 patients]
    Sigmund Silber
    Klinik Dr Müller, Munchen
    Herz 27:30-55. 2002
  3. ncbi Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients
    Sigmund Silber
    Cardiology Practice in the Dr Müller Hospital, Munich, Germany
    J Interv Cardiol 16:485-90. 2003
  4. ncbi Direct stent implantation using the EXPRESS Coronary Stent System: results of a multi-center feasibility study
    Sigmund Silber
    Internistische Klinik Dr Müller, Herzkatheterlabor Cardiology Associates, Munich, Germany
    J Interv Cardiol 16:491-7. 2003
  5. ncbi [2d Report on increasing volume of diagnostic and interventional heart catheterization in hospitals and private practice in Germany 1990-1999]
    S Silber
    Herzkatheterlabor der kardiologischen Gemeinschaftspraxis in der Klinik Dr Müller Am Isarkanal 36 81379 München Deutschland
    Herz 26:161-5. 2001
  6. ncbi Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II
    Sigmund Silber
    Cardiology Practice and Hospital, Munich, Germany
    Herz 29:171-80. 2004
  7. ncbi The IST registry
    Sigmund Silber
    Dr Muller Hospital, Am Isarkanal 36, 81379 Munich, Germany
    Z Kardiol 91:33-9. 2002
  8. ncbi [Antiproliferative coated stents and intracoronary brachytherapy: common traits and differences]
    S Silber
    Kardiologische Praxis in der Klinik Dr Müller Am Isarkanal 36 81379 München, Germany
    Z Kardiol 91:443-57. 2002
  9. ncbi Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times
    S Silber
    Dr Muller Hospital, Am Isarkanal 36, Munich 81379, Germany
    J Invasive Cardiol 11:19B-24B. 1999
  10. ncbi Final report of the European multi-center registry using the Duett vascular sealing device
    S Silber
    Dr Muller Hospital, Munich, Germany
    Herz 24:620-3. 1999

Collaborators

Detail Information

Publications80

  1. ncbi [Undertreatment in secondary prevention of patients with coronary heart disease after revascularization]
    S Silber
    Herzkatheterlabor, Klinik Dr Müller, Munchen
    Herz 25:623-6. 2000
    ....
  2. ncbi [Intracoronary radiation therapy in controlled and open clinical trials with afterloading systems and "hot" balloon catheters. Analysis of 6,692 patients]
    Sigmund Silber
    Klinik Dr Müller, Munchen
    Herz 27:30-55. 2002
    ..But for in-stent restenoses, intracoronary brachytherapy is the only evidence-based interventional form of therapy...
  3. ncbi Paclitaxel-eluting stents: are they all equal? An analysis of six randomized controlled trials in de novo lesions of 3,319 patients
    Sigmund Silber
    Cardiology Practice in the Dr Müller Hospital, Munich, Germany
    J Interv Cardiol 16:485-90. 2003
    ..In contrast, polymer-based paclitaxel elution produced significant clinical benefit...
  4. ncbi Direct stent implantation using the EXPRESS Coronary Stent System: results of a multi-center feasibility study
    Sigmund Silber
    Internistische Klinik Dr Müller, Herzkatheterlabor Cardiology Associates, Munich, Germany
    J Interv Cardiol 16:491-7. 2003
    ..No other MACE were observed during the three-month follow-up period. Based on the findings of this study, direct stenting with the EXPRESS Stent appears feasible and is well tolerated...
  5. ncbi [2d Report on increasing volume of diagnostic and interventional heart catheterization in hospitals and private practice in Germany 1990-1999]
    S Silber
    Herzkatheterlabor der kardiologischen Gemeinschaftspraxis in der Klinik Dr Müller Am Isarkanal 36 81379 München Deutschland
    Herz 26:161-5. 2001
    ..The real optimal need for DIAG and PCI in Germany, however, has to be determined...
  6. ncbi Direct stenting with TAXUS stents seems to be as safe and effective as with predilatation. A post hoc analysis of TAXUS II
    Sigmund Silber
    Cardiology Practice and Hospital, Munich, Germany
    Herz 29:171-80. 2004
    ..While predilatation was recommended per protocol, direct stenting was not forbidden: thus, direct stenting was performed in 49 patients (TAXUS n = 23, control n = 26)...
  7. ncbi The IST registry
    Sigmund Silber
    Dr Muller Hospital, Am Isarkanal 36, 81379 Munich, Germany
    Z Kardiol 91:33-9. 2002
    ..At present, neither the physician's service nor the material costs are reimbursed. The IST Registry can furthermore be used as a comparative database regarding long-term outcome following implantation of antiproliferative-coated stents...
  8. ncbi [Antiproliferative coated stents and intracoronary brachytherapy: common traits and differences]
    S Silber
    Kardiologische Praxis in der Klinik Dr Müller Am Isarkanal 36 81379 München, Germany
    Z Kardiol 91:443-57. 2002
    ..This overview compares the status quo of both methods, concluding first practical considerations...
  9. ncbi Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times
    S Silber
    Dr Muller Hospital, Am Isarkanal 36, Munich 81379, Germany
    J Invasive Cardiol 11:19B-24B. 1999
    ..Although the incidence of medium or large hematoma was low, the trend towards a decreased risk of smaller hematomas seemed to be counterbalanced by an increased risk of larger hematomas...
  10. ncbi Final report of the European multi-center registry using the Duett vascular sealing device
    S Silber
    Dr Muller Hospital, Munich, Germany
    Herz 24:620-3. 1999
    ..The incidence of major complications is low and comparable to all other approved vascular closure devices and manual compression. CE-mark certification was approved at the end of 1998...
  11. ncbi A novel vascular sealing device for closure of percutaneous arterial access sites
    S Silber
    Department of Cardiology, Dr Muller Hospital, Munich, Germany
    Am J Cardiol 83:1248-52. 1999
    ..These promising first human results will need to be confirmed by a multicenter randomized trial...
  12. ncbi Usefulness of collagen plugging with VasoSeal after PTCA as compared to manual compression with identical sheath dwell times
    S Silber
    Dr Muller Hospital, Munich, Germany
    Cathet Cardiovasc Diagn 43:421-7. 1998
    ..Although the incidence of medium or large hematoma was low, the trend towards a decreased risk of smaller hematomas seemed to be counterbalanced by an increased risk of larger hematomas...
  13. ncbi [When are drug-eluting stents effective? A critical analysis of the presently available data]
    S Silber
    Kardiologische Praxis und Praxisklinik, Am Isarkanal 36, 81379 München, Germany
    Z Kardiol 93:649-63. 2004
    ..At the present time, these criteria have been met by only the Cypher and the Taxus stents...
  14. ncbi [First annual report of practitioners of interventional cardiology in private practice in Germany. Results of procedures of left heart catheterization and coronary interventions in the year 1996]
    S Silber
    Kardiologische Gemeinschaftspraxis, Klinik Dr Müller, Munchen
    Herz 23:47-57. 1998
    ..Thus, our newly developed software proved to be reliable, fast and easy to use. Participating centers receive immediate feedback regarding their position within the whole group...
  15. ncbi [Intracoronary brachytherapy with strontium/yttrium-90. Initial experiences in Germany]
    S Silber
    Kardiologische Gemeinschaftspraxis, Klinik Dr Müller, Munchen
    Herz 23:380-93. 1998
    ....
  16. doi [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010]
    S Silber
    Kardiologische Praxis und Praxisklinik, Akademische Lehrpraxis der Ludwig Maximilans Universität München, Am Isarkanal 36, 81379, Munchen
    Herz 35:558-64. 2010
    ..With the 12 months DAPT the patient is treated not the stent...
  17. ncbi [Impact of both cardiac-CT and cardiac-MR on the assessment of coronary risk]
    S Silber
    Kardiologische Praxis und Praxisklinik, Am Isarkanal 36, 81379 München
    Z Kardiol 94:IV/70-80. 2005
    ....
  18. ncbi [Second and Third Annual Report of the German Society of Coronary Angiography and Interventions in Private Practice (BNK) concerning quality assurance in invasive cardiology]
    S Silber
    Herzkatheterlabor der Kardiologischen Gemeinschaftspraxis, Klinik Dr Müller, Munchen
    Herz 25:143-50. 2000
    ..PTCA complications: the incidence of abrupt coronary occlusions was 2% and of emergency bypass surgery 0.4%; mortality was 0.1%...
  19. ncbi Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology
    Sigmund Silber
    Kardiologische Praxis und Praxisklinik, Munchen, Germany
    Eur Heart J 26:804-47. 2005
    ....
  20. ncbi Aberrant origin of the left main coronary artery arising from the right coronary artery associated with coronary artery disease: a case report
    A Beiras-Fernandez
    Department of Cardiac Surgery, Klinikum Grosshadern, LM University, Munich, Germany
    Heart Surg Forum 10:E173-4. 2007
    ..In this report, an aberrant origin of the left main coronary artery arising from the right coronary artery associated with coronary artery atherosclerosis and its surgical correction is described...
  21. doi [Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT)]
    Sigmund Silber
    Kardiologische Praxis und Praxisklinik, Akademische Lehrpraxis der Ludwig Maximilians Universität München, Am Isarkanal 36, Munich, Germany
    Med Klin (Munich) 103:638-45. 2008
    ..The concordance of several cardiovascular risk scores (PROCAM Score, Framingham Score and ESC Score) and its agreement with the treating physicians' risk assessment is unclear...
  22. ncbi [Quantification of coronary artery calcifications in the risk stratification of cardiac events]
    S Silber
    Herzkatheterlabor, Munchen, Germany
    Dtsch Med Wochenschr 127:2575-8. 2002
  23. ncbi [Early detection of myocardial infarct risk with cardio-CT. Can coronary calcium calculation prevention sudden cardiac death?]
    S Silber
    Kardiologische Gemeinschaftspraxis und Herzdiagnostikzentrum, Munchen
    MMW Fortschr Med 145:37-40. 2003
    ..The recently presented St. Francis Heart Study has shown that calcium scoring provides a significantly higher prognostic value than the traditional Framingham score...
  24. ncbi [Importance of ECG-triggering with the multi-slice CT for ruling out coronary calcification in individuals without diagnosed coronary disease]
    S Silber
    Herzdiagnostikzentrum hdz, Munchen
    Herz 26:260-72. 2001
    ..The "gold standard" for calcium scanning is traditionally ECG-triggered electron beam tomography (EBT). In addition, mechanical multi-slice CTs (MSCT) have been used without ECG-triggering for more than 6 years for calcium scanning...
  25. ncbi [Emergencies in the doctor's office. Bleeding from the puncture site after coronary angiography]
    P Lochow
    Herzkatheterlabor der kardiologischen Gemeinschftspraxis in der Klinik Dr Müller, Munchen
    MMW Fortschr Med 145:40-2. 2003
  26. ncbi [10 years of arterial closure devices: a critical analysis of their use after PTCA]
    S Silber
    Herzkatheterlabor in der Klinik Dr Müller, Munchen
    Z Kardiol 89:383-9. 2000
    ..The increased patient comfort is essentially related to the ability of sheath removal immediately after PTCA. Vascular closure devices reduce the burden of medical staff and decrease hospital costs by earlier discharge...
  27. ncbi [Safety and feasibility of intracoronary brachytherapy with the Novoste system within the scope of international multicenter studies]
    S Silber
    Kardiologischen Gemeinschaftspraxis in der Klinik Dr Müller, Munchen
    Z Kardiol 89:323-9. 2000
    ..d. Patients with stent implantation in the same session received 250 mg b.i.d. Ticlopidin or 75 mg Clopidogrel o.d. for at least three months. Total mortality and infarct rate was 0. There was no acute, subacute or late stent thrombosis...
  28. ncbi [Off-label use of clopidogrel after coronary stent implantation in Germany: optional or mandatory?]
    Sigmund Silber
    Richtlinienkomitee für Koronarinterventionen der Europäischen Gesellschaft für Kardiologie ESC, Herzkatheterlabor der kardiologischen Gemeinschaftpraxis in der Klinik Dr Müller, Munich
    Herz 28:65-71. 2003
    ..The threat of fines to physicians prescribing clopdiogrel at the expense of the social health care insurance is counterproductive and jeopardizes the life of the patients...
  29. ncbi [Noninvasive angiography of coronary bypass grafts with cardio-CT in a cardiology practice]
    Sigmund Silber
    Kardiologische Gemeinschaftpraxis and Herzdiagnostikzentrum, Munich, Germany
    Herz 28:126-35. 2003
    ..This paper describes our first experiences with MSCT in our cardiology practice and regards whether this new method provides relevant information for a cardiology practice...
  30. ncbi Two-year clinical follow-up of 90Sr/90 Y beta-radiation versus placebo control for the treatment of in-stent restenosis
    Sigmund Silber
    Dr Mueller Hospital, Munich, Germany
    Am Heart J 149:689-94. 2005
    ..STents And Restenosis Trial (START) was the first placebo-controlled randomized trial for in-stent restenosis with beta-radiation; herein, we report the 2-year clinical follow-up...
  31. doi Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry
    Ibrahim Akin
    Department of Cardiology, University Hospital Rostock, Rostock School of Medicine, Ernst Heydemann Strasse 6, Rostock, Germany
    Catheter Cardiovasc Interv 76:50-7. 2010
    ..DE registry provides real world data to evaluate the therapeutic principle of two different drug-eluting stents (DES) [Sirolimus- (SES) and Paclitaxel-eluting stent (PES)] in the context of the German Health System...
  32. ncbi Cypher versus taxus: are there differences?
    Sigmund Silber
    Cardiology Practice and Hospital, Munich, Germany
    J Interv Cardiol 18:441-6. 2005
    ..A trial proving the superiority of one DES over another would require a multicenter study with a clinical primary endpoint at an adequate power. As long as such a trial does not exist, Cypher and Taxus are regarded as being equivalent...
  33. ncbi Which parameter should be chosen as primary endpoint for randomized drug-eluting stent studies?
    Sigmund Silber
    Dr Muller Hospital, Munich, Germany
    J Interv Cardiol 17:375-85. 2004
    ..Although the angiographic results of other drug-eluting stents are encouraging, they will have to prove their clinical impact based on adequately powered randomized trials with a primary clinical endpoint at an adequate time interval...
  34. ncbi Capturing circulating endothelial progenitor cells: a new concept tested in the HEALING studies
    S Silber
    Cardiology Practice and Hospital, Munich, Germany
    Minerva Cardioangiol 54:1-3. 2006
  35. ncbi [Percutaneous coronary interventions. Guidelines of the European Society of Cardiology-ESC]
    Sigmund Silber
    Kardiologische Praxis und Praxklinik, Am Isarkanal 36, 81379 München, Germany
    Kardiol Pol 63:265-320; discussion 321-3. 2005
  36. ncbi [Arguments in favor of Integrated Health Care as regular health care provision in cardiology]
    S Silber
    1 Vorsitzender des Bundesverbandes Niedergelassener Kardiologen e V BNK, Kardiologische Gemeinschaftspraxis und Praxisklinik, Am Isarkanal 36, 81379 München
    Clin Res Cardiol 95:II37-40. 2006
    ..Reimbursement should not be designed according to conventional systems for outpatient or inpatient care, but as defined sums of money. That makes people sure to know what kind of contract they have agreed in...
  37. ncbi [Working instructions in the cardiac catheter laboratory. According to paragraph 18 (2): Radiographic regulation for a radiography facility for the use of x-rays with humans as a model]
    S Silber
    Kardiologische Gemeinschaftspraxis und Praxisklinik in der Klinik Dr Müller, Am Isarkanal 36, 81379 München, Germany
    Clin Res Cardiol 95:72-5. 2006
  38. pmc Clinical and angiographic acute and follow up results of intracoronary beta brachytherapy in saphenous vein bypass grafts: a subgroup analysis of the multicentre European registry of intraluminal coronary beta brachytherapy (RENO)
    T M Schiele
    Medizinische Klinik Innenstadt, University Hospital, Munich, Germany
    Heart 89:640-4. 2003
    ..To assess clinically and angiographically the feasibility, safety, and effectiveness of vascular brachytherapy (VBT) in saphenous vein bypass grafts (SVG)...
  39. ncbi Sheath pulling immediately after PTCA: comparison of two different deployment techniques for the hemostatic puncture closure device: a prospective, randomized study
    S Silber
    Dr Muller Hospital, Munich, Germany
    Cathet Cardiovasc Diagn 41:378-83. 1997
    ....
  40. ncbi Final 5-year results of the TAXUS II trial: a randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for de novo coronary artery lesions
    Sigmund Silber
    Cardiology Practice and Hospital, Am Isarkanal 36, D 81379 Munich, Germany
    Circulation 120:1498-504. 2009
    ....
  41. doi [Optimal platelet inhibition after coronary stent implantation. Current status]
    Sigmund Silber
    Kardiologische Praxis und Praxisklinik, Akademische Lehrpraxis der Ludwig Maximilians Universität München, Munchen
    Herz 33:244-53. 2008
    ....
  42. ncbi [Evidence-based application of cardiac magnetic resonance and cardiac computed tomography for primary diagnosis of stable coronary artery disease with special attention to disease management programs and the German National Medical Care Guidelines]
    Sigmund Silber
    Kardiologische Praxis, Herzdiagnostikzentrum und Praxisklinik, Akademische Lehrpraxis der Ludwig Maximilians Universität München, Am Isarkanal 36, 81379, Munchen, Germany
    Herz 32:139-58. 2007
    ....
  43. ncbi [Drug-eluting stents for diabetic patients. A critical appraisal of the currently available data from randomized trials]
    Sigmund Silber
    Kardiologische Praxis und Praxisklinik, Akademische Lehrpraxis der Ludwig Maximilians Universität München, Munchen
    Herz 33:196-205. 2008
    ..This overview compiles the currently available data from randomized trials and meta-analyses...
  44. ncbi Inadequate medical treatment of patients with coronary artery disease by primary care physicians in Germany
    B Bischoff
    Cardiology Practice and Heart Diagnostic Center, Am Isarkanal 36, 81379 Munich, Germany
    Clin Res Cardiol 95:405-12. 2006
    ..The DETECT study was performed to obtain representative data about the frequency, distribution, and treatment of patients with coronary artery disease (CAD) in the primary care setting in Germany...
  45. ncbi Age and gender distribution of coronary artery calcium measured by four-slice computed tomography in 2,030 persons with no symptoms of coronary artery disease
    Axel Schmermund
    Department of Cardiology, University Clinic, Essen, Germany
    Am J Cardiol 90:168-73. 2002
  46. ncbi A new and rapid scoring system to assess the scientific evidence from clinical trials
    Sigmund Silber
    Cardiology Practice and Hospital, Munich, Germany
    J Interv Cardiol 19:485-92. 2006
    ..The new scoring system suggested here should help make decisions regarding which treatment to use and stimulate discussions...
  47. ncbi High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial
    Eberhard Grube
    J Am Coll Cardiol 44:1368-72. 2004
    ..Santa Clara, California/Boston Scientific Corp., Natick, Massachusetts) versus uncoated control stents (n = 140) in focal, de novo coronary lesions...
  48. ncbi [Heart catheter in angina pectoris: must we set stricter indications?]
    Sigmund Silber
    Vorsitzender des Bundesverbandes Niedergel Kardiologen BNK, Munchen
    MMW Fortschr Med 148:13. 2006
  49. ncbi [After the heart catheter. 2 thrombocyte inhibitors for a whole year?]
    Sigmund Silber
    MMW Fortschr Med 145:16. 2003
  50. ncbi TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions
    Eberhard Grube
    Department of Cardiology Angiology, Heart Center Siegburg, Siegburg, Germany
    Circulation 107:38-42. 2003
    ..The TAXUS I trial was the first in-human experience evaluating safety and feasibility of the TAXUS NIRx stent system compared with bare NIR stents (control) (Boston Scientific Corp) for treatment of coronary lesions...
  51. ncbi [Drug-eluting stents: breakthrough or time bomb]
    Thomas F Luscher
    Herz 32:265-7. 2007
  52. ncbi Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies
    Joachim Schofer
    Center for Cardiology and Vascular Intervention, Hamburg, Germany
    Herz 29:195-200. 2004
    ..The incomplete evidence to date is that implantation of sirolimus-eluting stents in patients with AMI is safe and effective...
  53. ncbi [Brachytherapy and "evidence based medicine": we must wait longer for the solution]
    Sigmund Silber
    Dtsch Med Wochenschr 127:1967; author reply 1967-8. 2002
  54. ncbi Impact of vessel size, lesion length and diabetes mellitus on angiographic restenosis outcomes: insights from the NIRTOP study
    Ran Kornowski
    Rabin Medical Center, Petach Tikva, Israel
    Acute Card Care 10:104-10. 2008
    ..The primary objective of the current analysis was to define the impact of vessel size, lesion length, and diabetes on clinical and angiographic restenosis following implantation of the NIRFLEX stent...
  55. ncbi Randomized comparison of success and adverse event rates and cost effectiveness of one long versus two short stents for treatment of long coronary narrowings
    Rainer Hoffmann
    Medical Clinic I, University Aachen, Aachen, Germany
    Am J Cardiol 90:460-4. 2002
    ..The restenosis rate is not reduced by the use of 1 long stent compared with 2 stents. However, long stent placement is highly cost effective...
  56. ncbi Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis
    Jeffrey J Popma
    Interventional Cardiology, Brigham and Women s Hospital, Boston, Mass 02115, USA
    Circulation 106:1090-6. 2002
    ..We report the first multicenter, blinded, and randomized trial of intracoronary radiation with the use of a 90Sr/90Y beta-source for the treatment of in-stent restenosis...
  57. ncbi Rotational atherectomy does not reduce recurrent in-stent restenosis: results of the angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST)
    Juergen vom Dahl
    Medizinische Klinik I, Universitatsklinikum, Rheinisch Westfaelische Technische Hochschule Aachen, Germany
    Circulation 105:583-8. 2002
    ....
  58. ncbi A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation
    Peter W Radke
    Medical Clinic I, RWTH University Hospital Aachen, Aachen, Germany
    Am Heart J 152:761.e1-6. 2006
    ..The AACHEN trial was a double-blind, randomized, placebo-controlled clinical multicenter trial to evaluate the effects of candesartan cilexetil on intimal hyperplasia after coronary stent implantation...
  59. ncbi [4th report of German Association of Cardiologists in private practice (BNK) on quality assurance in cardiac catheterization and coronary intervention 1999-2002]
    Benny Levenson
    Steering Committee des QuIK Registers des BNK, Berlin
    Herz 28:335-47. 2003
    ..Two out of three of the centers underwent a monitoring/auditing process in 2002. The desirable post-interventional follow-up after discharge in all cases appears to be impossible to fulfill under the given economical circumstances...
  60. ncbi Successful reduction of in-stent restenosis in long lesions using beta-radiation--subanalysis from the RENO registry
    Dietrich Baumgart
    University Essen, Essen, Germany
    Int J Radiat Oncol Biol Phys 58:817-27. 2004
    ..Although intracoronary gamma-radiation has been proved to reduce diffuse in-stent restenosis in long lesions, such an effect remains to be determined using beta-radiation...
  61. ncbi [Guidelines for percutaneous coronary interventions]
    Sigmund Silber
    Ital Heart J Suppl 6:427-74. 2005
  62. ncbi Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT)
    Remo Albiero
    Columbus Hospital, Milan, Italy
    J Am Coll Cardiol 43:943-9. 2004
    ..e., percutaneous transluminal coronary angioplasty [PTCA]) for the treatment of patients with coronary in-stent restenosis (ISR)...
  63. ncbi Two-year-plus follow-up of a paclitaxel-eluting stent in de novo coronary narrowings (TAXUS I)
    Eberhard Grube
    Heart Center Siegburg, Siegburg, Germany
    Am J Cardiol 96:79-82. 2005
    ..The single target vessel revascularization in the TAXUS group was remote from the target lesion in contrast to 3 target lesion revascularizations in the control group...
  64. ncbi [Guidelines for percutaneous coronary interventions]
    Sigmund Silber
    Rev Esp Cardiol 58:679-728. 2005
  65. ncbi Intracoronary brachytherapy, a promising treatment option for diabetic patients: Results from a European multicenter registry (RENO)
    Christoph K Naber
    West German Heart Center, University Hospital Essen, Essen, Germany
    Catheter Cardiovasc Interv 61:173-8. 2004
    ..Thus, intracoronary brachytherapy represents a promising treatment option for diabetic patients...
  66. ncbi Clinical outcome following combination of cutting balloon angioplasty and coronary beta-radiation for in-stent restenosis: a report from the RENO registry
    Christian Roguelov
    Division of Cardiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
    J Invasive Cardiol 15:706-9. 2003
    ..27 0.88; p = 0.02). Compared to conventional angioplasty, cutting balloon angioplasty prior to coronary beta-radiation with the Beta-Cath System seems to improve the 6-month clinical outcome in patients with in-stent restenosis...
  67. ncbi Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes
    Mohan Suntharalingam
    Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore 21201, USA
    Int J Radiat Oncol Biol Phys 57:536-42. 2003
    ....
  68. ncbi Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions
    Antonio Colombo
    Ospedale San Raffaele, Milano, Italy
    Circulation 108:788-94. 2003
    ..Early clinical studies demonstrated the feasibility of local paclitaxel delivery in reducing restenosis after treatment of de novo coronary lesions in small patient populations...
  69. ncbi The NUGGET study: NIR ultra gold-gilded equivalency trial
    Nicolaus Reifart
    Main Taunus Heart Institute, Bad Soden, Germany
    Catheter Cardiovasc Interv 62:18-25. 2004
    ..e., higher neointimal hyperplasia in spite of a significantly better initial gain), with higher restenosis and similar MACE rates at 6 months...
  70. ncbi [European study of ambulatory management of heart failure by cardiologists]
    María J Salvador
    Rev Esp Cardiol 57:1170-8. 2004
    ..This cross-sectional study examined the overall clinical characteristics and management of 1252 outpatients with heart failure in 3 countries (Spain, France and Germany)...
  71. ncbi [Universal definition of the myocardial infarction]
    Kristian Thygesen
    Department of Medicine and Cardiology, Aarhus University Hospital, Dania
    Kardiol Pol 66:47-62. 2008
  72. doi Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients
    Harald Jorn Schneider
    Institute of Clinical Psychology and Psychotherapy, Technical University of Dresden, 01187, Dresden, Germany
    Eur J Endocrinol 158:153-61. 2008
    ..We aimed at investigating the association of age-dependent IGF-I SDS with diabetes, dyslipidemia, hypertension, and heart diseases, in a large patient sample...
  73. ncbi Universal definition of myocardial infarction
    Kristian Thygesen
    Circulation 116:2634-53. 2007
  74. ncbi [Cardio-MR and cardio-CT: quo vadis?]
    Udo Sechtem
    Herz 28:73. 2003
  75. ncbi European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by r
    Ian Graham
    Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Doublin, Ireland
    Eur J Cardiovasc Prev Rehabil 14:E1-40. 2007
  76. ncbi Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association
    Panos E Vardas
    Department of Cardiology, Heraklion University Hospital, PO Box 1352 Stavrakia, GR 711 10 Heraklion Crete, Greece
    Eur Heart J 28:2256-95. 2007
  77. ncbi Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology
    Jean Pierre Bassand
    Members of the Board of the European Society of Cardiology
    Eur Heart J 26:2733-41. 2005
    ....
  78. ncbi [Reperfusion treatment of acute myocardial infarct. Guidelines of European Cardiological Society]
    Jean Pierre Bassand
    Członkowie Zarzadu Europejskiego Towarzystwa Kardiologicznego
    Kardiol Pol 64:161-72; discussion 173-6. 2006
  79. ncbi [Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care]
    David Pittrow
    Institut fur Klinische Pharmakologie, Forschungsverbund Public Health, Technische Universitat Dresden, Dresden, Germany
    Med Klin (Munich) 101:635-44. 2006
    ....
  80. ncbi European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by represent
    Ian Graham
    Department of Cardiology, The Adelaide and Meath Hospital, Tallaght, Dublin, Ireland
    Eur J Cardiovasc Prev Rehabil 14:S1-113. 2007